Literature DB >> 28611978

Periodontal Pathogens in the Etiology of Pancreatic Cancer.

Mesut Öğrendik1.   

Abstract

BACKGROUND: Pancreatic cancer is the fourth leading cause of cancer-related deaths worldwide. Chronic pancreatitis is frequently observed in patients with pancreatic cancer, and a significant relationship between orodigestive cancer-related deaths and chronic periodontitis has been detected. Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola, collectively called the Red complex, are the major pathogens responsible for chronic periodontitis and secrete peptidylarginine deiminase. Anti-P. gingivalis antibodies titers are higher in pancreatic cancer patients than in healthy subjects.
SUMMARY: This review examines the association between oral bacteria and the etiology of pancreatic cancer. KEY MESSAGE: High rates of tumor suppressor gene p53 mutations, particularly p53 arginine mutations, were detected in pancreatic cancer patients. K-ras arginine mutations were detected in patients with pancreatic cancer. Oral bacteria peptidylarginine deiminases might lead to the p53 and K-ras point mutations by degrading arginine. PRACTICAL IMPLICATIONS: Oral bacteria are likely to be responsible for the development of pancreatic cancer. If this hypothesis is true, it may reveal the real cause of pancreatic cancer, which is a fatal disease.

Entities:  

Keywords:  Etiology; Pancreatic cancer; Periodontal pathogens

Year:  2016        PMID: 28611978      PMCID: PMC5465713          DOI: 10.1159/000452708

Source DB:  PubMed          Journal:  Gastrointest Tumors        ISSN: 2296-3774


  13 in total

1.  KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinoma.

Authors:  Bruno V Sinn; Jana K Striefler; Marc A Rudl; Annika Lehmann; Marcus Bahra; Carsten Denkert; Marianne Sinn; Jens Stieler; Frederick Klauschen; Jan Budczies; Wilko Weichert; Albrecht Stenzinger; Carsten Kamphues; Manfred Dietel; Hanno Riess
Journal:  Pancreas       Date:  2014-05       Impact factor: 3.327

2.  Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality.

Authors:  Jiyoung Ahn; Stephanie Segers; Richard B Hayes
Journal:  Carcinogenesis       Date:  2012-02-26       Impact factor: 4.944

3.  Associations between P53 Arg72Pro and development of digestive tract cancers: a meta-analysis.

Authors:  Liu Liu; Kai Wang; Zheng-Ming Zhu; Jiang-Hua Shao
Journal:  Arch Med Res       Date:  2011-01       Impact factor: 2.235

4.  Analysis of K-ras gene mutations in human pancreatic cancer cell lines and in bile samples from patients with pancreatic and biliary cancers.

Authors:  T Evans; M Faircloth; A Deery; V Thomas; A Turner; A Dalgleish
Journal:  Oncol Rep       Date:  1997 Nov-Dec       Impact factor: 3.906

Review 5.  Epidemiology of pancreas cancer (1988).

Authors:  P Boyle; C C Hsieh; P Maisonneuve; C La Vecchia; G J Macfarlane; A M Walker; D Trichopoulos
Journal:  Int J Pancreatol       Date:  1989-12

Review 6.  Role of bacterial infections in pancreatic cancer.

Authors:  Dominique S Michaud
Journal:  Carcinogenesis       Date:  2013-07-10       Impact factor: 4.944

7.  Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study.

Authors:  Dominique S Michaud; Jacques Izard; Charlotte S Wilhelm-Benartzi; Doo-Ho You; Verena A Grote; Anne Tjønneland; Christina C Dahm; Kim Overvad; Mazda Jenab; Veronika Fedirko; Marie Christine Boutron-Ruault; Françoise Clavel-Chapelon; Antoine Racine; Rudolf Kaaks; Heiner Boeing; Jana Foerster; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Carlotta Sacerdote; Sabina Sieri; Domenico Palli; Rosario Tumino; Salvatore Panico; Peter D Siersema; Petra H M Peeters; Eiliv Lund; Aurelio Barricarte; José-María Huerta; Esther Molina-Montes; Miren Dorronsoro; J Ramón Quirós; Eric J Duell; Weimin Ye; Malin Sund; Björn Lindkvist; Dorthe Johansen; Kay-Tee Khaw; Nick Wareham; Ruth C Travis; Paolo Vineis; H Bas Bueno-de-Mesquita; Elio Riboli
Journal:  Gut       Date:  2012-09-18       Impact factor: 23.059

8.  A comprehensive survey of Ras mutations in cancer.

Authors:  Ian A Prior; Paul D Lewis; Carla Mattos
Journal:  Cancer Res       Date:  2012-05-15       Impact factor: 12.701

9.  Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.

Authors:  C M Barton; S L Staddon; C M Hughes; P A Hall; C O'Sullivan; G Klöppel; B Theis; R C Russell; J Neoptolemos; R C Williamson
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

10.  Detection of K-ras point mutations at codon 12 in pancreatic juice for the diagnosis of pancreatic cancer by hybridization protection assay: a simple method for the determination of the types of point mutation.

Authors:  H Watanabe; C Miyagi; Y Yamaguchi; Y Satomura; H Ohta; Y Motoo; T Okai; T Yoshimura; Y Tsuji; N Sawabu
Journal:  Jpn J Cancer Res       Date:  1996-05
View more
  23 in total

1.  Tumor microbiome links cellular programs and immunity in pancreatic cancer.

Authors:  Bassel Ghaddar; Antara Biswas; Chris Harris; M Bishr Omary; Darren R Carpizo; Martin J Blaser; Subhajyoti De
Journal:  Cancer Cell       Date:  2022-10-10       Impact factor: 38.585

2.  Porphyromonas gingivalis infection exacerbates oesophageal cancer and promotes resistance to neoadjuvant chemotherapy.

Authors:  Shegan Gao; Yiwen Liu; Xiaoxian Duan; Ke Liu; Muddasir Mohammed; Zhen Gu; Junling Ren; Lan Yakoumatos; Xiang Yuan; Lanhai Lu; Shuang Liang; Jiong Li; David A Scott; Richard J Lamont; Fuyou Zhou; Huizhi Wang
Journal:  Br J Cancer       Date:  2021-05-12       Impact factor: 7.640

3.  Impact of a novel oral health promotion program on routine oral hygiene among socioeconomically disadvantaged smokers: results from a randomized semi-pragmatic trial.

Authors:  Jennifer B McClure; Melissa L Anderson; Chloe Krakauer; Paula Blasi; Terry Bush; Jennifer Nelson; Sheryl L Catz
Journal:  Transl Behav Med       Date:  2020-05-20       Impact factor: 3.046

Review 4.  The microbiota and microbiome in pancreatic cancer: more influential than expected.

Authors:  Miao-Yan Wei; Si Shi; Chen Liang; Qing-Cai Meng; Jie Hua; Yi-Yin Zhang; Jiang Liu; Bo Zhang; Jin Xu; Xian-Jun Yu
Journal:  Mol Cancer       Date:  2019-05-20       Impact factor: 27.401

5.  Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer.

Authors:  Rogier Aäron Gaiser; Asif Halimi; Hassan Alkharaan; Liyan Lu; Haleh Davanian; Katie Healy; Luisa W Hugerth; Zeeshan Ateeb; Roberto Valente; Carlos Fernández Moro; Marco Del Chiaro; Margaret Sällberg Chen
Journal:  Gut       Date:  2019-03-14       Impact factor: 23.059

Review 6.  Oncobiosis and Microbial Metabolite Signaling in Pancreatic Adenocarcinoma.

Authors:  Borbála Kiss; Edit Mikó; Éva Sebő; Judit Toth; Gyula Ujlaki; Judit Szabó; Karen Uray; Péter Bai; Péter Árkosy
Journal:  Cancers (Basel)       Date:  2020-04-25       Impact factor: 6.639

7.  CircRNA_000864 Upregulates B-cell Translocation Gene 2 Expression and Represses Migration and Invasion in Pancreatic Cancer Cells by Binding to miR-361-3p.

Authors:  Linsheng Huang; Junxiang Han; Huifan Yu; Jialing Liu; Lili Gui; Zhengkun Wu; Xinxu Zhao; Shiqi Su; Gaohang Fu; Fei Li
Journal:  Front Oncol       Date:  2020-12-23       Impact factor: 6.244

Review 8.  The oralome and its dysbiosis: New insights into oral microbiome-host interactions.

Authors:  Allan Radaic; Yvonne L Kapila
Journal:  Comput Struct Biotechnol J       Date:  2021-02-27       Impact factor: 7.271

Review 9.  Role of the microbiome in occurrence, development and treatment of pancreatic cancer.

Authors:  Yicheng Wang; Gang Yang; Lei You; Jinshou Yang; Mengyu Feng; Jiangdong Qiu; Fangyu Zhao; Yueze Liu; Zhe Cao; Lianfang Zheng; Taiping Zhang; Yupei Zhao
Journal:  Mol Cancer       Date:  2019-12-01       Impact factor: 27.401

10.  Periodontal pathogens promote cancer aggressivity via TLR/MyD88 triggered activation of Integrin/FAK signaling that is therapeutically reversible by a probiotic bacteriocin.

Authors:  Pachiyappan Kamarajan; Islam Ateia; Jae M Shin; J Christopher Fenno; Charles Le; Ling Zhan; Ana Chang; Richard Darveau; Yvonne L Kapila
Journal:  PLoS Pathog       Date:  2020-10-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.